At Munich’s real estate exhibition last week, Russia’s leading e-commerce company, Ulmart, hosted a “working breakfast” to discuss the nuances and intricacies of investing in Russia today during times of heightened international tension.
The topic, “Making the Case for Star Investment Projects in Russia”, featured Ulmart’s chairman and majority shareholder Dmitry Kostygin; Andrew Kaye, Managing Director and Co-Head of Technology Banking, William Blair International; Calin Anton Business Development Director Russia & CIS, Astron; and, Tim Millard, Regional Director, Head of Consulting Services at Jones Lang LaSalle, Russia.
A lively discussion kicked off about how some in the investment community tend to focus—even obsess—on macro realties at a state-to-state level ignoring many truly interesting project; precisely the types of projects that keep most of the world’s economies developing positively from cycle to cycle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7660751-ulmart-russian-investment-update/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
At the end of the year and as we approach PR Newswire’s 60th anniversary in March, there is a natural inclination to reflect. At PR Newswire, we are just as interested in looking forward to the future for communicators of all kinds – PR, corporate, marketing and shareholder – and their audiences. While technology continues to evolve and new communication channels continue to emerge, everyone at PR Newswire remains focused on helping brands and organizations earn targeted attention from consumers, investors and the media by amplifying our clients’ narratives and making their content more discoverable.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/64514-happy-new-year-from-pr-newswire-2014
CenturyLink, Inc., the nation’s third-largest telecommunications company and a global leader in cloud infrastructure and hosted IT solutions, today is launching a new advertising campaign across the U.S. designed to highlight the company’s advanced network, managed hosting and cloud capabilities.
In television, print and online ads, CenturyLink is reinforcing its commitment to being a business partner that provides leading global broadband, cloud infrastructure and hosted IT solutions. The campaign is about freeing businesses to focus on innovation and growth by providing them with dedicated, responsive support and the capabilities needed to make their business even more reliable, secure and agile.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60744-centurylink-new-u-s-advertising-campaign-aimed-at-businesses-of-all-sizes
The 2018 Niro Plug-in Hybrid (PHEV) brings an exciting new dimension to Kia's alternative fuel car line-up. As Kia's third plug-in model, and anticipated in retailer showrooms by the end of this year, the Niro PHEV offers the same crossover utility, fun-driving and winning design of the Niro hybrid, but with an estimated 26-miles of All-Electric Range.1
“The Niro Plug-in is the exciting next step in Kia's progression toward offering more alternative fuel vehicles by 2020,” said Orth Hedrick, vice president, product planning, Kia Motors America (KMA). “Consumers who are intrigued by the Niro hybrid's fantastic versatility and design, but want even more EcoDynamics technology and the ability to drive only using electric power, will find more to love in the Niro Plug-in Hybrid.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8016958-kia-niro-plug-in-hybrid-crossover-laas/
Introducing the next major version of the TMA - Travelport Mobile Agent developed by TTS - Travel Technology & Solutions. This video is a quick preview of some of the new features included in TMA 2.0 for iOS. Main new features: - Full tutorial, - Support for masked commands, - Support for any GDS operation, - Advanced PKeys, - Linked commands, - Terminal pinch to zoom, - Text selection, - Copy to clipboard, - Send by email (selection, current screen or all pages), - Print to AirPrinter (selection, current screen or all pages), - Keyboard always open, - Support for external Bluetooth keyboard, - Performance increase, - Faster boot time, TMA 2.0 is already available in the Apple App Store. You can download it at http://itunes.apple.com/app/travelport-mobile-agent/id447792568?mt=8
A whopping 80 percent of enterprises are investing today in AI, but one in three business leaders believe their company will need to invest more over the next 36 months to keep pace with competitors. At the same time, enterprises are anticipating significant barriers to adoption and are looking to strategize against those issues by creating a new C-suite position, the Chief AI Officer (CAIO), to streamline and coordinate AI adoption. These results come from a survey of 260 large organizations that operate globally, conducted by leading technology industry market research firm Vanson Bourne on behalf of Teradata (NYSE: TDC), the leading data and analytics company.
“There is an important trend emerging evident in this report — enterprises today see AI as a strategic priority that will help them outpace the competition in their respective industries,” says Atif Kureishy, Vice President, Emerging Practices at Think Big Analytics, a Teradata company. “But to leverage the full potential of this technology and gain maximum ROI, these businesses will need to revamp their core strategies so AI has an embedded role from the data center to the boardroom.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8075951-teradata-state-of-artificial-intelligence-ai-for-enterprises/
Adlens, the global leader in adjustable focus eyewear, has launched its ground-breaking adjustable prescription eyewear ‘AdlensFocuss™’, the greatest advancement in optics in more than 50 years.
Vision inevitably changes with age and people often need different strength glasses to see at near, intermediate and far distances. Progressive lenses are an option but they have a restricted usable lens area. A GFK Roper Study has shown one-third of wearers say they have trouble adjusting to them with seven to eight percent of wearers saying they cannot adjust to them at all.
AdlensFocuss provides the benefits of a single vision lens – full frame viewing area – with the best features of a progressive lens – the ability to see at different distances. They are prescription glasses with proprietary technology; a unique flexible membrane that allows the power to be adjusted by simply turning small dials on the inside of the frames. AdlensFocuss lenses offer at least four times more viewing area than traditional progressive lenses and come encased in a fashion-forward frame from award-winning designer Blake Kuwahara.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7544851-adlensfocuss-optics-technology/
Oura Health, the Finnish health technology company behind the Oura ring, has moved its total private funding to 12.5M€ after the closure of a round led by US-based Bold Capital Partners and Finland’s Tesi. The funding will be used to scale US market operations and push the Oura platform forward.
The Oura ring and app guides wearers towards better sleep, recovery and readiness to perform by analyzing the body’s sleep, activity levels, daily rhythms and physiological responses.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8362451-oura-health-strengthens-position-us-market/
NOAA’s Joint Polar Satellite System-1 (JPSS-1) is encapsulated inside the fairing (nose cone) of a United Launch Alliance Delta II launch vehicle ready for lift off from Space Launch Complex-2W at Vandenberg Air Force Base, California, on November 14, 2017 at 1:47 a.m., PST. JPSS-1 is a collaborative effort between NOAA and NASA.
“The JPSS-1 bus is based on our Ball Configurable Platform 2000, a proven, agile spacecraft, which has 50 years of on-orbit operations and is designed for cost-effective, remote sensing applications,” said Alex Chernushin, JPSS-1 Program Manager, Ball Aerospace. “JPSS-1 is the twelfth spacecraft built on this core architecture, including the Suomi National Polar-orbiting Partnership (Suomi NPP) spacecraft launched in 2011.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7987651-ball-aerospace-joint-polar-satellite-system-jpss-1-launch/
Abbott announced today the U.S. Food and Drug Administration approval and launch of the iDesign Advanced WaveScan Studio System. The system acts as the "brain" of the LASIK procedure, generating a high-definition scan that measures and maps irregularities of the eye that may impact vision. From these measurements, the iDesign System creates an accurate and personalized LASIK treatment plan based on the unique "blueprint" of each person’s eyes.
The iDesign System captures more than 1,200 micro readings of the eye, as well as identifying the shape of the cornea, its curvature, how light passes through the eye and pupil diameter under different lighting conditions – all in one, three-second scan that can be used to precisely correct vision.
The development of the sensor technology within the iDesign System was the result of an earlier discovery by Abbott scientists, which NASA used to accurately measure and shape the mirrors in the James Webb Space Telescope to ensure it will transmit high resolution images of deep space back to earth. The telescope is scheduled to launch in 2018.
To view the Multimedia News Release, please go to http://www.multivu.com/players/English/7571951-abbott-idesign-system-3-d-eye-map/
Hyundai Motor Company today unveiled its G90 premium luxury sedan for the Genesis brand in the U.S. market, the new flagship of the brand’s model line-up. The 2017 G90 will compete at the top of the premium luxury car segment with world-class technological innovations and the highest levels of refinement, convenience and dynamic performance.
Created by the new Prestige Design Group, G90 provides strong indications of the brand’s ‘Athletic Elegance’ design identity that will be evident in future Genesis products. The G90 silhouette is both powerful and refined, from its prominent hood, generous wheelbase, minimized overhangs and sophisticated rear deck surfacing. Inside the cabin, fine materials and textures from around the world meet refined ergonomics to provide occupants with absolute convenience and luxurious comfort.
To view the multimedia release go to:
http://www.multivu.com/players/English/75060510-hyundai-genesis-g90-luxury-sedan/
